
    
      Sleep apnea is a sleep disorder characterized by pauses in breathing during sleep. This study
      will compare the use of eszopiclone to placebo for subjects with mild to moderate obstructive
      sleep Apnea syndrome (OSAS). Frequency and duration of apnea and hypopnea episodes, oxygen
      saturation, objective sleep parameters and safety information will be collected in this
      study. This study was previously posted by Sepracor Inc. In October 2009, Sepracor Inc. was
      acquired by Dainippon Sumitomo Pharma., and in October 2010, Sepracor Inc's name was changed
      to Sunovion Pharmaceuticals Inc.
    
  